Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer.

Cancer discovery·2026

Same author

Selpercatinib in Early-Stage <i>RET</i> Fusion-Positive Non-Small-Cell Lung Cancer.

The New England journal of medicine·2026

Same author

Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with <i>ALK-</i>Positive Non-Small Cell Lung Cancer.

Cancer communications (London, England)·2026

Same author

Antibody-Drug Conjugates in Non-small Cell Lung Cancer.

Drugs·2026

Same author

Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysis.

The oncologist·2026

Same author

Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic Therapies.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026

Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026

Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 10, 2025

Experimental Metastasis Assay

Experimental Metastasis Assay

Published on: August 24, 2010

Lung metastases.

Lodovica Zullo^1,2, Dimitris Filippiadis³, Lizza E L Hendriks⁴

¹Cancer Medicine Department, Gustave Roussy, Villejuif, France.

Nature Reviews. Disease Primers

|August 21, 2025

Summary

This summary is machine-generated.

Lung metastases, common in metastatic cancer, significantly worsen prognosis and quality of life. Understanding the pre-metastatic niche formation is key to developing targeted therapies for lung cancer metastasis.

More Related Videos

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Published on: May 20, 2020

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

Related Experiment Videos

Last Updated: Sep 10, 2025

Experimental Metastasis Assay

Experimental Metastasis Assay

Published on: August 24, 2010

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells

Published on: May 20, 2020

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

Area of Science:

Oncology
Cancer Metastasis Research
Pulmonary Medicine

Background:

Lung metastases affect up to 50% of patients with metastatic cancer, leading to poor prognosis.
These metastases impair patient quality of life through symptoms like dyspnea and pain.
The development of lung metastases involves complex tumor-secreted factors and microenvironment alterations.

Purpose of the Study:

To review the mechanisms of lung metastasis formation.
To discuss diagnostic approaches for lung metastases.
To highlight current treatment strategies and future therapeutic directions.

Main Methods:

Literature review of mechanisms driving lung metastasis.
Analysis of diagnostic methods including imaging and histology.
Synthesis of information on current and potential treatments for lung metastases.

Main Results:

Tumor factors (VEGF, TGFβ, CCL2), exosomes, and microparticles promote a pre-metastatic niche in the lungs.
Diagnosis relies on imaging, with histology sometimes needed to differentiate from primary lung cancer.
Treatment decisions consider metastasis characteristics and patient condition, often involving systemic therapy.

Conclusions:

Understanding pre-metastatic niche formation is crucial for developing novel prevention and treatment strategies.
Targeted therapies for lung metastases remain an unmet clinical need.
Future research into metastasis stages may yield tailored treatments.